Embracing a Precision Medicine Approach to KRAS G12C–Mutated Advanced NSCLC
Precision medicine revolutionized NSCLC treatment, targeting specific mutations like KRAS G12C with therapies such as adagrasib to improve patient outcomes.
Source: pharmacytimes.com